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Abstract: Although magnesium (Mg) is a unique biodegradable metal which 
possesses mechanical property similar to that of the natural bone and can be 
an attractive material to be used as orthopedic implants, its quick corrosion 
rate restricts its actual clinical applications. To control its rapid degradation, 
we have modified the surface of magnesium implant using fluoridated 
hydroxyapatite (FHA: Ca10(PO4)6OH2 − xFx) through the combined micro-arc 
oxidation (MAO) and electrophoretic deposition (EPD) techniques, which was 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Materials Science and Engineering: C, Vol 48 (March 2015): pg. 21-27. DOI. This article is © Elsevier and permission has 
been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article 
to be further copied/distributed or hosted elsewhere without the express permission from Elsevier. 
3 
 
presented in our previous paper. In this article, the biocompatibility 
examinations were conducted on the coated AZ91 magnesium alloy by 
implanting it into the greater trochanter area of rabbits. The results of the in 
vivo animal test revealed a significant enhancement in the biocompatibility of 
FHA/MAO coated implant compared to the uncoated one. By applying the 
FHA/MAO coating on the AZ91 implant, the amount of weight loss and 
magnesium ion release in blood plasma decreased. According to the 
histological results, the formation of the new bone increased and the 
inflammation decreased around the implant. In addition, the implantation of 
the uncoated AZ91 alloy accompanied by the release of hydrogen gas around 
the implant; this release was suppressed by applying the coated implant. Our 
study exemplifies that the surface coating of magnesium implant using a 
bioactive ceramic such as fluoridated hydroxyapatite may improve the 
biocompatibility of the implant to make it suitable as a commercialized 
biomedical product. 
Keywords: Bioabsorbable magnesium alloy, Coating, Surface modification, 
Fluoridated hydroxyapatite, in vivo 
1. Introduction 
Bio-metals such as titanium alloys and stainless steels have 
been commonly utilized as orthopedic implants due to their mechanical 
strength.1 However, mechanical properties of these materials vary 
vastly from those of the human bone, which may lead to the “stress-
shielding” problem.2 Moreover, the corrosion products of some of these 
alloys may cause long-standing unfavorable effects.1 Since the metal 
implants are used as permanent devices such as pins, screws, nails 
and bone plates, they remain as a foreign body to the host tissues 
even after the completion of healing process, and may need to be 
extracted by a post-surgical procedure. The second surgery not only 
increases the health care cost, but it may contribute to the patient's 
morbidity.3 
Absorbable biocompatible materials may be a proper solution 
since they eventually dissolve in body fluid.4,5 Several polymers, 
ceramics and nanocomposites have been developed as degradable 
biomedical materials.6,7 However, they lack appropriate mechanical 
properties and cannot be used for load-bearing applications.2,8 
Magnesium (Mg) and its alloys have recently been known as a 
bioabsorbable bone implant materials, since they possess mechanical 
properties similar to those of the human bone with an appropriate 
biocompatibility.9,10 However, in spite of the advantages of magnesium 
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alloys, they have not been commercialized yet.11 The foremost 
drawback reported for magnesium alloys has been related to their high 
corrosion rate in the physiological environment.12,13 For that reason, an 
initially low or ideally a controllable absorbable rate is wanted to avoid 
further deterioration of the adjacent tissue.14,15 
If the magnesium implants are being used to fix damage bone 
tissue, they are likely to lose their mechanical integrity earlier than 
tissue healing of bone due to their rapid corrosion and low 
bioactivity.16,17 Recently, some research has been planned to slow 
down the corrosion rate of magnesium alloys.18,19 Surface modification 
and coating by various materials has been employed as a proper 
approach for controlling the corrosion properties of metals since 
decades ago with excellent rate of success.20,21 The reduction of the 
corrosion rate of magnesium alloys may also be achieved by 
appropriate surface treatment.22,23 If the coating material is bioactive, 
it not only decreases the corrosion rate, but it can also improve the 
biocompatibility which is necessary for the use of magnesium alloys.24 
Hydroxyapatite (HA) with the chemical composition of 
Ca10(PO4)6(OH)2 has been extensively used as bioactive coating 
materials for hard tissue devices. The replacement of F− ion instead of 
OH− group in HA composition gives a bioactive ceramic with the 
chemical composition of Ca10(PO4)6OH2 − xFx; where x stands for the 
degree of fluoridation which is called fluoridated hydroxyapatite (FHA). 
FHA is beneficial to improve some key properties of HA; it has lower 
absorbable rate and better bioactivity compared to HA, and hence FHA 
has the potential to be used as a decent coating material for 
bioabsorbable magnesium alloys.25,26 
In addition, the biological properties of a coating may be 
improved if it is made in nanostructural configuration similar to the 
structure of natural bone.27 Thus, in this paper, we planned to prepare 
a nanostructured FHA coating on Mg alloy implants. Electrophoretic 
deposition (EPD) is known as an inexpensive and easily applicable 
method of coating that has been broadly used for surface coating of 
bioactive ceramics on metallic implants including stainless steels, 
cobalt and titanium alloys.28 In this paper, we utilized EPD technique 
for coating of the FHA layer. However, EPD would be more effective if 
it applied on a porous structure. Thus, as an intermediate layer on the 
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magnesium alloys, micro-arc oxidation (MAO) has been introduced on 
the surface of the Mg substrate. It not only can produce a porous 
template for the EPD coating layer, but it also can act as a barrier 
layer for corrosion attacks due to the existence of MgO in its chemical 
composition.22,29  
There has been some research separately on MAO coating,29,30,31 
and FHA coating by electrodeposition technique32,33 on magnesium 
alloys. In our previous work, we employed a combination of MAO and 
EPD techniques for the surface modification of AZ91 magnesium alloy 
by FHA coating which exhibits a significant property enhancement of 
implants. The coating performance, the bioactivity, and the corrosion 
resistance have been discussed in our previous paper.34 In this article, 
we have developed our analysis on the in vitro and in vivo 
biocompatibility of FHA/MAO coated implants in comparison with both 
MAO coated and uncoated AZ91 substrates. 
2. Materials and methods 
Preparation of FHA/MAO coating on AZ91 magnesium alloy 
substrates was explicitly explained in our previously published work in 
which the detailed study on the fabrication, characterization, corrosion 
behavior and bioactivity of the samples was presented.34 Briefly, plate 
samples with dimensions of 20 × 15 × 5 mm3 were cut from an AZ91 
magnesium alloy ingot. Afterward, they were ground with SiC papers 
to 600 grits and then were sonicated in acetone. The FHA powder was 
prepared using sol–gel technique. To prepare FHA, 1.227 g of 
phosphorous pentoxide (P2O5) was added into a beaker containing 
20 mL ethanol. Another solution including 7 g calcium nitrate 
tetrahydrate (Ca(NO3)2·4H2O, Merck) and 20 mL of absolute ethanol 
was prepared separately and added to the previous solution. For 
incorporation of fluorine ion, 70.28 μl hexafluorophosphoric acid (HPF6) 
was added into the mixture. The mixture was stirred for about 20 h to 
form a viscous gel. The gel was dried in an oven and heat treated at 
600 °C for 1 h. The produced powders were milled for 10 h with the 
ball/powder ratio of 10/1 and rotational speed of 250 rpm to achieve 
the nanostructured FHA powder. 
The MAO process was conducted on a direct current (DC) power 
supply. The prepared AZ91 samples and a stainless steel plate were 
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placed as the anode and cathode respectively inside an electrolyte 
solution composed of 200 g/L Na2SiO3 and 200 g/L NaOH. The voltage 
was applied step by step to reach 60 V for half an hour. The coated 
samples were removed from the electrolyte solution, cleaned with 
acetone and dried at room temperature which was approximately 
25 °C. 
To perform the EPD process, the powder was used in as-
received condition to produce EPD suspension containing 100 g/L of 
FHA particles in methanol. The dispersion process was carried out 
using ultrasonication and magnetic stirring. In order to disperse the 
particles inside the solution, the prepared suspension was placed into 
an ultrasonic bath for about 20 min. Afterwards, the dispersion process 
was carried out using magnetic stirring. The MAO sample and a 
graphite rod were placed at the location of cathode and anode, 
respectively. Electrophoretic deposition was started by setting the 
constant voltage at 100 V, deposition time of 3 min and electrode 
separation of 2 cm. 
The size of produced FHA nanoparticles was measured using a 
transmission electron microscope (TEM: JEOL JEM-2100). The surface 
crystal structure of the samples (before and after the immersion test) 
was analyzed using a scanning electron microscope (SEM: Philips XL 
30: Eindhoven) equipped with energy-dispersive X-ray spectroscopy 
(EDX). A laser scanning microscope (Keyence, VK X100/X200), 
equipped with a VK analyzer was used in order to observe the surface 
of coated samples. An adhesion tester (PosiTest AT-A, USA) was 
employed to determine the adherence strength of coatings on the 
substrate. 
During the cell culture test, cell viability, pH values and Mg ion 
release of samples in the culture media were measured. For cell 
viability evaluation, L-929 cell line was cultured in 89% Dulbecco's 
modified Eagle's medium (DMEM, Gibco) supplemented with 10% fetal 
bovine serum (FBS, Gibco) and 1% penicillin streptomycin. The 
samples were sterilized and the cells were seeded onto the samples. 
Cell viability was evaluated after 2, 5, and 7 days of culture times. For 
this purpose, at each time point, the medium was replaced by MTT 
solution and the samples were incubated in this solution for 4 h. 
Finally, the medium was replaced by dimethylsulfoxide (DMSO). A 
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microplate reader measured the absorbance of samples. The cell 
viability was expressed as ODsample / ODcontrol ∗ 100%, where ODsample 
and ODcontrol were the optical density of the sample and the control, 
respectively. For the control group, cells were cultured on tissue 
culture polystyrene plate filled with DMED. In addition, the pH values 
and the Mg ion concentrations of the medium were evaluated. Analysis 
of variance (ANOVA) was performed for the statistical analysis and the 
statistical significance was defined as p < 0.05. 
For in vivo animal examinations, the implants were machined in 
rod shape with 3 mm diameter and 6 mm length. Adult rabbits were 
used in our study and the surgical procedure was conducted according 
to the requirements of the University Ethics Committee in the Animal 
Unit. The rabbits were anesthetized with Ketamine, Xylazine and 
Acepromazine. After anesthesia, the operation site was shaved and 
decortication was carried out. A hand driller was utilized to make a 
hole of 3 mm diameter into the greater trochanter area of rabbits. The 
rod samples were implanted inside the holes and the wound was 
sutured layer-by-layer. All rabbits received an injection of antibiotics at 
the end of the operation. The rabbits were euthanized after 2 months. 
Meanwhile, the X-ray radiography and blood test were performed 
during this period. Then, the bone samples including the implants were 
taken out to detect the new bone formation around the implants via 
histological analysis. For this purpose, the bone samples were 
decalcified by nitric acid and were stained with Hematoxylin and Eosin 
(H&E). A light microscope was utilized to observe the changes in bone 
structure around the implants. 
3. Results and discussion 
As can be seen in the TEM image of Fig. 1a, the size of the FHA 
nanoparticles are in the range of 50–100 nm with agglomerative 
configuration. The XRD pattern of nanoparticles in Fig. 1b represents 
the expected crystallized peaks of FHA. According to SEM image of 
Fig. 1c, the surface of MAO coating has a rough morphology containing 
several pores. This structure was formed by releasing the gas bubbles 
in molten oxide during the arcs. XRD pattern of the MAO coating in 
Fig. 1d detects Mg, MgO and Mg2SiO4 peaks in the MAO coating. MgO 
is formed by dissolving Mg2 + from the AZ91 substrate and its chemical 
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reaction with the O2 − from the electrolyte. At higher temperature 
during the micro-arc oxidation process, both SiO2 and MgO are 
presented and form Mg2SiO4 (forsterite). MgO and Mg2SiO4 protect the 
substrate from the corrosion attacks and have positive effects on 
enhancing the bioactivity. The surface morphology of the FHA coating 
is illustrated in Fig. 1e. According to the SEM micrograph of FHA 
coating in this figure, it has a porous surface with a netlike structure. 
It has been suggested that this configuration can be supportive for cell 
attachment and proliferation, and may improve the biological fixation 
of the implant to the surrounding bone tissue. As can be seen in the 
XRD pattern of FHA coating in Fig. 1f, besides the diffraction peaks 
from the MAO (Mg, MgO and Mg2SiO4), the diffraction peaks from FHA 
were also detected, indicating that FHA has been coated as the main 
phase on the surface of MAO. 
 
Fig. 1. TEM image of FHA particles (a), XRD pattern of FHA particles (d), SEM 
micrograph of MAO coating (c), XRD pattern of MAO coating (d), SEM micrograph of 
FHA coating (e), and XRD pattern of FHA coating (f). 
The cross-sectional morphologies of the AZ91 (a), MAO (b) and 
FHA/MAO coated (c) samples have been presented in Fig. 2 which 
indicate that the thicknesses of MAO and FHA coating are 
approximately 100 and 250 μm, respectively. The FHA, with a rough 
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morphology, has been deposited on the surface of MAO coating. 
Different phases including AZ91, MAO coating and FHA/MAO coating 
can be observed in SEM micrographs. The EDS line-scan analysis as an 
inset in Fig. 2c shows that the FHA coating mainly contains of Ca, Mg, 
and P elements. As can be seen in Fig. 2c, the intensities of Ca and P 
decrease and the intensity of Mg increases from FHA/MAO coating to 
the AZ91 substrate, as the coating layer contains Ca and P. According 
to the laser scanning microscopy images (Fig. 2d, e, f), the MAO 
coating has bumpy morphology compared to the AZ91 substrate with 
roughness of about 15 μm. The roughness of FHA/MAO coating is 
approximately 200 μm which is significantly more than that of the MAO 
coating. Several islands (red color) with the approximate height of 
500 μm can be observed in Fig. 2f. Small submicron surface roughness 
can be observed on the FHA/MAO coating according to the line scan 
profilometry analysis (Fig. 2i). The measured roughness values for red 
and blue islands are approximately 7 and 11 μm for red and blue 
islands, respectively. 
 
Fig. 2. Cross-sectional morphology of the AZ91 (a), MAO (b) and FHA/MAO (c) coated 
samples, three dimensional laser scanning microscopy images of the AZ91 (d), MAO 
(e) and FHA/MAO (f) coated samples, and surface profilometry analysis of AZ91 (g), 
MAO (h) and FHA/MAO (i) coated samples. 
Since the MAO coating has a high strength metallurgical binding 
with the AZ91 substrate, the adhesion tester was not able to measure 
the adherence strength. However, the adherence strength between the 
FHA/MAO coating and MAO coating was measured 6.5 ± 0.3 MPa. 
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Table 1 presents the results of the cell viability in 2, 5, and 
7 days of culture times. For all samples, the cell viability increased 
with culture time. The cell viability of AZ91 sample increased from 
50% after 2 days to 58% after 7 days of culture time. The cell viability 
of MAO sample increased from 70% after 2 days to 85% after 7 days 
of culture time and for FHA/MAO coated sample, the cell viability 
increased from 160% after 2 days of culture time to 175% after 
7 days of incubation. Thus, the FHA/MAO coated sample presented a 
superior cell viability compared to others. This indicated that the 
coated samples have significantly more initial cytocompatibility than 
the uncoated sample. It is worth mentioning that the FHA/MAO coated 
sample has shown cell viability over 100% in all culture times. 
According to the cell viability calculation in the present study (cell 
viability = ODsample / ODcontrol × 100), the cell viability is over 100% 
when the optical density of a sample (ODsample) is more than that of the 
control group (ODcontrol) which denotes that the sample possesses more 
viable cells compared to the control group confirming the good 
proliferation of cells on that sample. In the present study, the amount 
of cell viability of FHA/MAO coated sample (160% after 2 days and 
175% after 7 days) indicates that the sample was not cytotoxic, and 
the FHA/MAO coated sample facilitated the cell proliferation. 
Table 1. The results of cell viability in 2, 5, and 7 days of culture times. 
Samples 2 (days) 5 (days) 7 (days) 
AZ91 magnesium alloy 50 ± 3 55 ± 5 58 ± 7% 
MAO coating 70 ± 5 80 ± 6 85 ± 7% 
FHA/MAO coating 160 ± 9 170 ± 10 175 ± 9% 
The pH values of DMEM culture medium during the cell culture 
test for AZ91, MAO, and FHA/MAO coated samples are shown in 
Fig. 3a. According to Fig. 3a, the pH value of AZ91 sample after 2 days 
was 8.8 which reached 9.5 after 7 days. The pH value of MAO sample 
after 2 days and 7 days was 8.1 and 8.8, respectively. For the 
FHA/MAO coated sample, the pH value changed from 7.8 after 2 days 
to 8.1 after 7 days. The pH increase is mostly as a result of the 
releasing the OH− group in the medium. The less increase of pH value 
of the medium containing the MAO and FHA/MAO coated sample for 
the period of the cell culture shows a comparatively slow corrosion and 
an improvement of the corrosion resistance of MAO and FHA/MAO 
coating. Fig. 3b shows the Mg ion release of the samples during the 
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cell culture test. According to Fig. 3b, the Mg ion concentration after 
2 days for AZ91, MAO, and FHA/MAO coated samples was 22, 18, and 
13 ppm, respectively. After 7 days, the Mg ion concentration increased 
to 30, 25, and 17 ppm for AZ91, MAO, and FHA/MAO coated samples, 
respectively. Thus, according to the results, for all samples the Mg ion 
concentration increased with the culture time, however, the lowest Mg 
ion concentration was found for FHA/MAO coated samples indicating 
the least corrosion rate compared to the others. 
 
Fig. 3. pH values of DMEM culture medium (a) and Mg ion release (b) of AZ91, MAO, 
and FHA/MAO coated samples during the cell culture test in DMEM culture medium 
showing the corrosion behavior of samples during the cell culture test. 
The environmental variations including pH changes and Mg ion 
release in the culture medium affect the cell viability. The fast increase 
of pH value leads to less viability and proliferation of cells. In addition, 
Mg ion release is accompanied by the production of hydrogen bubbles 
from the surface. The hydrogen evolution can be an important obstacle 
for cell attachment.35 The surface modification of magnesium substrate 
can significantly decrease the corrosion rate leading to less change in 
pH value and Mg ion release.33 In our study, FHA/MAO coating on the 
magnesium substrate reduces the pH increase and Mg ion release 
leads to the best cell viability compared to other samples. Moreover, 
having calcium element in the chemical composition of FHA coating 
can be helpful on the cellular behavior, as it improves the chemical 
signaling of the cells and absorbs fibronectin and vitronectin proteins 
which are crucial elements on the biological function of the cells.36 
The AZ91 (a), MAO (d), and FHA/MAO coated (g) samples were 
implanted into the greater trochanter of rabbits and the surgery 
images are presented in Fig. 4. According to the post-operation 
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veterinary examinations, clinical signs as a result of swelling, pain or 
alteration were not detected. The formation of gas bubbles below the 
skin was not detected and good wound healing was observed after the 
surgery. The X-ray radiography images from AZ91 (Fig. 4b), MAO 
(Fig. 4e) and FHA/MAO coated (Fig. 4h) implants were taken off the 
rabbits 2 weeks after the surgery. The gas bubbles around the AZ91 
implants (black area) were more than other implants due to the higher 
corrosion rate, however, almost no gas bubbles were found around the 
FHA/MAO coated implants. Note that the absorption of hydrogen gas 
usually occurs in longer times as a result of decreasing the corrosion 
rate due to the formation of corrosion products on the surface.35 Other 
researchers have also mentioned that the visible subcutaneous 
hydrogen bubbles appeared in the first days after the surgery and 
disappeared after 2–3 weeks.37 After euthanizing the rabbits, 
pathological examinations were carried out on the bone tissue around 
implantation region of the AZ91 (Fig. 4c), MAO (Fig. 4f), and FHA/MAO 
coated (Fig. 4i) implants. Comparing the histological images of 
different samples, one may notice that the new bone formed around 
the FHA/MAO coated implants was more than the others and 
conversely the inflammation was less than others. The level of the 
volume percentage of new bone formation around the implants was in 
the following order: FHA/MAO coating (60%) > MAO (31%) > AZ91 
(27%). Lower release of hydrogen bubbles around the FHA/MAO 
coated implants due to the lower corrosion rate led to the more bone 
formation and less inflammation compared to other samples. 
Furthermore, the existence of Ca and P elements in the chemical 
composition of FHA can stimulate the osteoblastic cells and improve 
the osteoconductivity.24 Immune response to implants generally 
comprises the hypersensitivity related to implants.38 Observation of 
hypersensitivity reactions in surrounding tissues upon discharging the 
corrosion products suggests that there is a correlation between 
corrosion and metal hypersensitivity.39 Moreover, metals suffering 
from wear process release wear particles which may provoke 
undesirable reactions in patients and cause inflammation which 
consequently may loosen the implant.40 Phagocytic cells take up 
corrosion products and particles, and generate pro-inflammatory 
cytokines. The inflammation endures by releasing more particles from 
the implant, and possibly by self-perpetuating cytokine-driven 
procedures. The pro-inflammatory surrounding stimulates the 
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generation of bone resorbing cells, and consequently the patient may 
experience severe bone loss and implant loosening, followed by pain 
and limitation of motion as symptoms of metallosis.41 Although, the 
microscopic inflammation could be observed in the bone tissue around 
the implants of our experiment according to histological images, there 
was no sign of macroscopic inflammations in veterinary examinations. 
 
Fig. 4. The surgery images of AZ91 (a), MAO (d), and FHA/MAO coated (g) samples, 
the X-ray radiography images from AZ91 (b), MAO (e), and FHA/MAO coated (h) 
samples and the histological analysis of AZ91 (c), MAO (f), and FHA/MAO coated (i) 
samples implanted into the greater trochanter of rabbits. 
The results of the blood test to detect the changes of serum 
magnesium level in blood plasma for AZ91, MAO, and FHA/MAO coated 
implants before implantation and after 2 weeks, 1 and 2 months of 
post-operation are presented in Fig. 5. Before the surgery, the serum 
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magnesium value was the same for all rabbits. Although it increased 
due to the corrosion of magnesium substrate, it was within the normal 
range of physiological magnesium level (20 ppm).42 However, 
according to the results, the difference between serum magnesium 
value before and after the surgery for FHA/MAO coated implants was 
less than others. 
 
Fig. 5. The results of the blood test to detect the changes of serum magnesium level 
in blood plasma for AZ91, MAO, and FHA/MAO coated implants before implantation 
and after 2 weeks, 1 and 2 months of post-operation. 
The weight variation of implants after euthanizing the rabbits 
was measured. The results indicated that the weight losses of AZ91, 
MAO, and FHA/MAO coated implants were 25, 16, and 4 mg/cm2, 
respectively. Thus, the weight loss of the FHA/MAO coated implant was 
significantly less than that of the other implants. It is worth noting that 
a large amount of magnesium ions is released during the corrosion of 
implants. However, no considerable increase is observed in the serum 
magnesium value. This may be due to the regulation of magnesium 
ions in the kidney and their excretion in the urine.24 
4. Conclusion 
In order to enhance the corrosion resistance of magnesium 
implants, we have modified the surface of AZ91 magnesium alloy 
using fluoridated hydroxyapatite through the micro-arc 
oxidation/electrophoretic deposition (MAO/EPD) technique. In 
continuation with our previous work, we completed our study on the 
coated and uncoated Mg implants by biocompatibility analyses 
including in vivo examinations. The results confirmed that the 
FHA/MAO coating noticeably improved the biocompatibility of AZ91 
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magnesium alloy implant. Thus, we recommend the bioabsorbable 
FHA/MAO coated Mg implant as a suitable candidate for future clinical 
orthopedic applications. 
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